Literature DB >> 27567994

Enthalpy screen of drug candidates.

Arne Schön1, Ernesto Freire2.   

Abstract

The enthalpic and entropic contributions to the binding affinity of drug candidates have been acknowledged to be important determinants of the quality of a drug molecule. These quantities, usually summarized in the thermodynamic signature, provide a rapid assessment of the forces that drive the binding of a ligand. Having access to the thermodynamic signature in the early stages of the drug discovery process will provide critical information towards the selection of the best drug candidates for development. In this paper, the Enthalpy Screen technique is presented. The enthalpy screen allows fast and accurate determination of the binding enthalpy for hundreds of ligands. As such, it appears to be ideally suited to aid in the ranking of the hundreds of hits that are usually identified after standard high throughput screening.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27567994      PMCID: PMC5035635          DOI: 10.1016/j.ab.2016.08.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  29 in total

1.  High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

Authors:  R L Rich; Y S Day; T A Morton; D G Myszka
Journal:  Anal Biochem       Date:  2001-09-15       Impact factor: 3.365

2.  Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.

Authors:  Hiroyasu Ohtaka; Arne Schön; Ernesto Freire
Journal:  Biochemistry       Date:  2003-11-25       Impact factor: 3.162

3.  Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.

Authors:  Hiroyasu Ohtaka; Adrian Velázquez-Campoy; Dong Xie; Ernesto Freire
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

Review 4.  Adaptive inhibitors of the HIV-1 protease.

Authors:  Hiroyasu Ohtaka; Ernesto Freire
Journal:  Prog Biophys Mol Biol       Date:  2005-06       Impact factor: 3.667

5.  Overcoming roadblocks in lead optimization: a thermodynamic perspective.

Authors:  Adam J Ruben; Yoshiaki Kiso; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2006-01       Impact factor: 2.817

Review 6.  Adding calorimetric data to decision making in lead discovery: a hot tip.

Authors:  John E Ladbury; Gerhard Klebe; Ernesto Freire
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

7.  Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry.

Authors:  B M Baker; K P Murphy
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

Review 8.  Clinical pharmacology and pharmacokinetics of amprenavir.

Authors:  Brian M Sadler; Daniel S Stein
Journal:  Ann Pharmacother       Date:  2002-01       Impact factor: 3.154

9.  Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.

Authors:  T Mimoto; R Kato; H Takaku; S Nojima; K Terashima; S Misawa; T Fukazawa; T Ueno; H Sato; M Shintani; Y Kiso; H Hayashi
Journal:  J Med Chem       Date:  1999-05-20       Impact factor: 7.446

Review 10.  Do enthalpy and entropy distinguish first in class from best in class?

Authors:  Ernesto Freire
Journal:  Drug Discov Today       Date:  2008-08-26       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.